Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 640,000 | 2,553,100 | 1,921,000 | 1,265,500 | 638,300 |
| Accounts payable and accrued liabilities | -488,000 | -2,058,200 | -1,531,300 | -1,084,900 | -560,300 |
| Other Working Capital | 121,900 | 349,000 | 268,400 | 105,100 | 51,800 |
| Other Operating Activity | -144,000 | -388,700 | -327,100 | -118,300 | -60,000 |
| Operating Cash Flow | $129,900 | $455,200 | $331,000 | $167,400 | $69,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 37,300 | 28,700 | 16,300 | 8,400 | -2,900 |
| PPE Investments | -34,400 | -165,500 | -122,600 | -82,400 | -40,200 |
| Net Acquisitions | N/A | N/A | -23,400 | N/A | N/A |
| Other Investing Activity | 0 | -23,400 | 0 | 0 | 0 |
| Investing Cash Flow | $2,900 | $-160,200 | $-129,700 | $-74,000 | $-43,100 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -100 | -400 | -400 | -300 | -200 |
| Common Stock Issued | 4,300 | 19,200 | 15,300 | 10,200 | 5,500 |
| Common Stock Repurchased | -101,900 | -203,600 | -203,600 | -105,700 | -4,700 |
| Other Financing Activity | 0 | -34,000 | -3,900 | -800 | -600 |
| Financing Cash Flow | $-97,700 | $-218,800 | $-192,600 | $-96,600 | $0 |
| Exchange Rate Effect | -1,800 | 9,200 | -900 | 6,500 | 2,700 |
| Beginning Cash Position | 489,800 | 404,400 | 404,400 | 404,400 | 404,400 |
| End Cash Position | 523,100 | 489,800 | 412,200 | 407,700 | 433,800 |
| Net Cash Flow | $33,300 | $85,400 | $7,800 | $3,300 | $29,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 129,900 | 455,200 | 331,000 | 167,400 | 69,800 |
| Capital Expenditure | -34,400 | -165,600 | -122,700 | -82,500 | -40,200 |
| Free Cash Flow | 95,500 | 289,600 | 208,300 | 84,900 | 29,600 |